Real-world data analysis suggests that families with at least one member using Novo Nordisk's GLP‑1 RA for weight management tend to reduce spending on alcohol and cigarettes. JAKARTA, Indonesia, Jan.

The latest investor updates on stocks that are trending on Monday.

Amazon Pharmacy announced it has begun selling Novo Nordisk’s new oral Wegovy pill, offering the weight loss medication for ...

Late Friday, Amazon said eligible customers with commercial insurance could pay as little as $25 for a one-month supply of ...

A new medical treatment could be significant for many people with obesity, as it no longer requires injections.

Now, it’s worth noting Stock Advisor’s total average return is 968 % — a market-crushing outperformance compared to 197% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...

Wegovy’s oral version of its injectable weight-loss drug is seeing tremendous interest, Novo Nordisk executive Dave Moore ...

Eli Lilly is riding the wave of a booming weight management market. Eli Lilly's tirzepatide, sold under the brand names ...

Novo Nordisk faces slowing growth, competition, regulatory risks, and Wegovy pricing pressure, with DCF showing fair ...

Eli Lilly (NYSE: LLY) and Johnson & Johnson (NYSE: JNJ) both delivered strong third-quarter results, but their earnings ...

The medication, available at a lower cost, is an alternative to injections and increases accessibility for patients, some ...

Wegovy is now available as a daily pill, but experts say strict dosing schedules and more intense side effects may not make it a better option than the injection.